Enhanced paromomycin efficacy by solid lipid nanoparticle formulation againstLeishmaniain mice model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced paromomycin efficacy by solid lipid nanoparticle formulation againstLeishmaniain mice model
Authors
Keywords
-
Journal
PARASITE IMMUNOLOGY
Volume 38, Issue 10, Pages 599-608
Publisher
Wiley
Online
2016-05-24
DOI
10.1111/pim.12340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent advances in topical formulation carriers of antifungal agents
- (2015) EmanAhmed Bseiso et al. Indian Journal of Dermatology Venereology & Leprology
- Natural Products: Insights into Leishmaniasis Inflammatory Response
- (2015) Igor A. Rodrigues et al. MEDIATORS OF INFLAMMATION
- Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems
- (2015) Maria Manuela Gaspar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics
- (2015) Moran Shalev et al. NUCLEIC ACIDS RESEARCH
- Topical Paromomycin and Gentamicin for New World Cutaneous Leishmaniasis in Panama
- (2014) Begoña Monge-Maillo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Chitosan-Assisted Immunotherapy for Intervention of Experimental Leishmaniasis via Amphotericin B-Loaded Solid Lipid Nanoparticles
- (2014) Vineet Jain et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- An update on pharmacotherapy for leishmaniasis
- (2014) Shyam Sundar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pharmacokinetics and Absorption of Paromomycin and Gentamicin from Topical Creams Used To Treat Cutaneous Leishmaniasis
- (2013) William R. Ravis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo
- (2013) Ping Wang et al. Materials Science & Engineering C-Materials for Biological Applications
- Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
- (2013) Afif Ben Salah et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Review of Preventative Methods against Human Leishmaniasis Infection
- (2013) Lisa Stockdale et al. PLoS Neglected Tropical Diseases
- Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice
- (2012) Neda Bavarsad et al. ACTA TROPICA
- Bioanalytical method development, pharmacokinetics, and toxicity studies of paromomycin and paromomycin loaded in albumin microspheres
- (2012) Wahid Khan et al. Drug Testing and Analysis
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Paromomycin loaded solid lipid nanoparticles: Characterization of production parameters
- (2011) Maryam Ghadiri et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment efficiency and particle size
- (2011) Maryam Ghadiri et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
- (2011) Delaram Doroud et al. JOURNAL OF CONTROLLED RELEASE
- Leishmaniasis: complexity at the host–pathogen interface
- (2011) Paul Kaye et al. NATURE REVIEWS MICROBIOLOGY
- Topical delivery andin vivoantileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis
- (2010) Guilherme Carneiro et al. JOURNAL OF LIPOSOME RESEARCH
- Antileishmanial activity in Israeli plants
- (2009) J. El-On et al. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
- Effect of Topical Liposomes Containing Paromomycin Sulfate in the Course of Leishmania major Infection in Susceptible BALB/c Mice
- (2009) M. R. Jaafari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmania majorMPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote Stage
- (2009) Miguel A. Morales et al. EUKARYOTIC CELL
- Leveraging biotech's drug discovery expertise for neglected diseases
- (2009) Joanna E Lowell et al. NATURE BIOTECHNOLOGY
- Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials
- (2009) Dae Hyun Kim et al. PLoS Neglected Tropical Diseases
- Local Suppression of T Cell Responses by Arginase-Induced L-Arginine Depletion in Nonhealing Leishmaniasis
- (2009) Manuel Modolell et al. PLoS Neglected Tropical Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now